The more athletes who follow Williamss lead, the more urgent the question of whether GLP-1s should be treated as performance-enhancing drugs will become
A single dose should not be divided
Sustained-release GLP-1 receptor agonists (GLP-1RAs) are a type of medication that slowly releases GLP-1RA into the bloodstream over time, which allows for longer-lasting effects and less frequent injections compared to traditional GLP-1RAs
Heres what that timeline typically looks like: Last GLP-1 injection Wait 2-3 months Begin ovarian stimulation (10-14 days) Egg retrieval Wait 3-5 days Embryo transfer This timeline ensures the medication is cleared before you take stimulation medications, allows your ovaries to return to baseline function, and provides a stable metabolic environment for implantation
For isotretinoin, Low-dose isotretinoin has fewer side effects, Dr
Physiologically, insulin resistance and compensatory hyperinsulinemia in T2DM may attenuate the incretin effect of GLP-1 RAs through impaired insulin signaling or reduced GLP-1 receptor responsiveness